Skip to Content

LCE 75 (Stalevo 75 18.75 mg / 200 mg / 75 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 75 is Red, Elliptical / Oval and has been identified as Stalevo 75 18.75 mg / 200 mg / 75 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 75 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 75 18.75 mg / 200 mg / 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 75

Stalevo 75

Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 75
Strength:
18.75 mg / 200 mg / 75 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00781-5625 Sandoz Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide